PHF21A
protein-codingPHD finger protein 21A, the group of PHD finger proteins
Gene summary
The PHF21A gene encodes BHC80, a component of a BRAF35 (MIM 605535)/histone deacetylase (HDAC; see MIM 601241) complex (BHC) that mediates repression of neuron-specific genes through the cis-regulatory element known as repressor element-1 (RE1) or neural restrictive silencer (NRS) (Hakimi et al., 2002 [PubMed 12032298]).[supplied by OMIM, Nov 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~192.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011022
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0032883
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*PHF21A* variants were first reported in relation to complex neurodevelopmental disorder in 2019 (PMID:30487643). The *PHF21A* gene encodes BHC80, a component of the BRAF35/HDAC complex that mediates repression of neuron-specific genes. At least 10 variants in *PHF21A*, including nonsense, frameshift and missense variants have been reported in the literature, with most variants occurring de novo. Patients with variants in this gene have been reported to have developmental delay, intellectual disability, and facial dysmorphism. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 10 probands in 2 publications (PMID: 30487643 and 31649809), including 6 frameshift, 3 nonsense (recurrent - c.1738C>T) and 1 missense (AT Hook region) (12 pts). Three of the frameshift variants are located at the last exons and are predicted to elongate the transcription product (PMID: 31649809). Due to limitations of the scoring interface, variants in two probands are not able to be formally entered. Patient 5 carries NM_001101802.1:c.1471_1472insT(p.Cys491LeufsTer?) and patient 7 carries NM_001101802.1:c.2024del(p.Gln675ArgfsTer?)) (PMID: 31649809). This gene-disease relationship is also supported by a zebrafish model that recapitulates some of the human disease phenotype (PMID:22770980) and a protein interaction study (PMID:12032298). In summary, there is definitive evidence to support the gene-disease relationship between *PHF21A* and complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 6, 2022 (SOP Version 8).
Inheritance Pattern: AD
Disease ID:MONDO:0032883
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032883
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PHF21A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001352027.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 67 | 7 | 78 | ||
| missense | 1 | 158 | 29 | 15 | 203 | |
| nonsense | 10 | 4 | 14 | |||
| start loss | 0 | |||||
| frameshift | 16 | 9 | 2 | 27 | ||
| splice donor/acceptor (+/-2bp) | 8 | 7 | 1 | 16 | ||
| Total | 27 | 21 | 171 | 97 | 22 | 338 |
Highest pathogenic variant AF is 0.000004794389
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001338956.1 | 16 | MANE Select | |
| Ensembl | ENSP00000502222.1 | 16 | MANE Select | |
| RefSeq | NP_001095272.1 | 16 | Standard | |
| RefSeq | NP_001338954.1 | 16 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| phf21ab | Danio rerio | Structure: aortic arch Quality: hypoplastic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Factors involved in megakaryocyte development and platelet production
- HDACs deacetylate histones
- Chromatin modifying enzymes
- Hemostasis
- Chromatin organization
Biological Process
- negative regulation of transcription by RNA polymerase II
- blood coagulation
- histone deacetylation
Molecular Function
- DNA binding
- chromatin binding
- histone deacetylase activity
- protein binding
- metal ion binding
Cellular Component
- histone deacetylase complex
- nucleoplasm
- DNA repair complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000418153
- Coding exons
- 16
- Length
- 192115
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.86 | 223 | 380 | 0.587 | 0.0000201 | 4444 |
| Missense (PolyPhen) | 68 | 153.12 | 0.44411 | 1865 | ||
| Synonymous | 1.17 | 124 | 142 | 0.875 | 0.00000789 | 1366 |
| Loss of Function | 5.64 | 0 | 37.1 | 0.00 | 0.00000192 | 395 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the BHC complex, a corepressor complex that represses transcription of neuron-specific genes in non-neuronal cells. The BHC complex is recruited at RE1/NRSE sites by REST and acts by deacetylating and demethylating specific sites on histones, thereby acting as a chromatin modifier. In the BHC complex, it may act as a scaffold. Inhibits KDM1A-mediated demethylation of 'Lys-4' of histone H3 in vitro, suggesting a role in demethylation regulation. {ECO:0000269|PubMed:16140033}.;
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- LoFtool
- 0.0517
- RVIS EVS
- -0.62
- RVIS percentile EVS
- 17.31
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |